Abstract
Purpose
To describe the clinical features and outcomes among eyes with choroidal neovascularization (CNV) in children and adolescents.
Methods
A total of 36 eyes of 27 patients <18 years of age diagnosed with CNV between January 1978 and December 2008 were retrospectively reviewed. CNV was clinically diagnosed in all patients and its presence was confirmed by fundus fluorescein angiography (FFA). A total of 19 eyes underwent treatment. Anatomical outcome was evaluated as regressed/persistent/recurrent CNV. Snellen’s values for best corrected visual acuity (BCVA) were converted to logMAR for statistical calculations.
Results
Of the 27 patients, 17 (63%) were male. Nine (33.3%) of the 27 patients had bilateral CNV. At presentation, CNV was active in 22 (61.1%) eyes and regressed in 14 (28.9%) eyes. All active CNV cases were ‘classic’ type, with the majority (80.5%) being subfoveal. The mean greatest linear dimension (GLD) was 3.16±1.94 mm (range, 0.9–10.15). The most common cause (41.7%) was post-inflammatory. The mean duration to regression in treated eyes was 103.53 days (15 eyes). Recurrence was noted in three (8.3%) eyes. The mean duration to first recurrence was 260 days (range, 90–390), and the mean follow-up duration was 779.53±988.00 days.
Conclusion
CNV remains a cause of significant visual decline in children and adolescents. Male predominance, post-inflammatory etiology, bilateral affection, and subfoveal location are noteworthy, with a high regression rate in response to treatment. Re-treatment is required in a limited number of cases.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Goshorn EB, Hoover DL, Eller AW, Friberg TR, Jarrett WH 2nd, Sorr EM . Subretinal neovascularization in children and adolescents. J Pediatr Ophthalmol Strabismus 1995; 32: 178–182.
Fine SL, Wood WJ, Isernhagen RD, Singerman LJ, Bressler NM, Folk JC et al. Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial. Arch Ophthalmol 1993; 111: 19–20.
Gilbert C, Foster A, Negrel AD, Thylefor B . Childhood blindness: a new form for recording causes of visual loss in children. Bull World Health Organ 1993; 71: 485–489.
World Health Organization. Report of WHO/IAPB Scientific Meeting, Childhood Blindness Prevention. WHO/PBL/87: London, 2001.
Cass HD, Sonsen PM, McConachie HR . Developmental setback in severe visual impairment. Arch Dis Child 1994; 70: 192–196.
Kobayashi K, Ohno-Matsui K, Kojima A, Shimada N, Yasuzumi K, Yoshida T et al. Fundus characteristics of high myopia in children. Jpn J Ophthalmol 2005; 49: 306–311.
Spraul CW, Grossniklaus HE . Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch Ophthalmol 1997; 115: 267–273.
Melberg NS, Thomas MA, Burgess DB . The surgical removal of subfoveal choroidal neovascularization. Ingrowth site as a predictor of visual outcome. Retina 1996; 16: 190–195.
Gass JD . Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol 1994; 118: 285–298.
Spaide RF . Choroidal neovascularization in younger patients. Curr Opin Ophthalmol 1999; 10: 177–181.
Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ . Etiology of choroidal neovascularization in young patients. Ophthalmology 1996; 103: 1241–1244.
Sivaprasad S, Moore AT . Choroidal neovascularisation in children. Br J Ophthalmol 2008; 92: 451–454.
Wilson ME, Mazur DO . Choroidal neovascularization in children: report of five cases and literature review. J Pediatr Ophthalmol Strabismus 1988; 25: 23–29.
Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group. Arch Ophthalmol 1991; 109: 1220–1231.
Mavrikakis E, Levin AV, Lam WC . Choroidal neovascularization secondary to congenital toxoplasmosis in an infant. Can J Ophthalmol 2010; 45: e11–e12.
Uemura A, Thomas MA . Visual outcome after surgical removal of choroidal neovascularization in pediatric patients. Arch Ophthalmol 2000; 118: 1373–1378.
Sears J, Capone A Jr, Aaberg T Sr, Lewis H, Grossniklaus H, Sternberg P Jr et al. Surgical management of subfoveal neovascularization in children. Ophthalmology 1999; 106: 920–924.
Christmas NJ, Oh KT, Oh DM, Folk JC . Long-term follow-up of patients with serpinginous choroiditis. Retina 2002; 22: 550–556.
Gupta V, Agarwal A, Gupta A, Bambery P, Narang S . Clinical characteristics of serpiginous choroidopathy in North India. Am J Ophthalmol 2002; 134: 47–56.
Erkkila H, Laatikainen L . A follow up study of serpiginous choroiditis. Acta Ophthalmol 1981; 59: 707–718.
Farah ME, Costa RA, Muccioli C, Guia TA, Belfort R Jr . Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2002; 134: 137–139.
Nowilaty SR, Bouhaimed M, Photodynamic Therapy Study Group. Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 2006; 90: 982–986.
Abu El-Asrar AM, Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D . Vogt-Koyanagi-Harada disease in children. Eye (Lond) 2008; 22: 1124–1131.
Tabbara KF, Chavis PS, Freeman WR . Vogt-Koyanagi-Harada syndrome in children compared to adults. Acta Ophthalmol Scand 1998; 76: 723–726.
Soheilian M, Aletaha M, Yazdani S, Dehghan MH, Peyman GA . Management of pediatric Vogt-Koyanagi-Harada (VKH)-associated panuveitis. Ocul Immunol Inflamm 2006; 14: 91–98.
Rubsamen PE, Gass JD . Vogt-Koyanagi-Harada syndrome. Clinical course, therapy and long term visual outcome. Arch Ophthalmol 1991; 109: 682–687.
Mauget-Faysse M, Mimoun G, Ruiz-Moreno JM, Quaranta-El Maftouhi M, De Laey JJ, Postelmans L et al. Verteporfin photodynamic therapy for choroidal neovascularization associated with toxoplasmic retinochoroiditis. Retina 2006; 26: 396–403.
Benevento JD, Jager RD, Noble AG, Latkany P, Mieler WF, Sautter M et alToxoplasmosis Study Group. Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy. Arch Ophthalmol 2008; 126: 1152–1156.
Rishi P, Venkataraman A, Rishi E . Combination photodynamic therapy and bevacizumab for choroidal neovascularization associated with toxoplasmosis. Indian J Ophthalmol 2011; 59: 62–64.
Giansanti F, Virgili G, Varano M, Tedeschi M, Rapizzi E, Giacomelli G et al. Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina 2005; 25: 590–596.
Chang JH, Wakefield D . Uveitis: a global perspective. Ocul Immunol Inflamm 2002; 10: 263–279 (Review).
Goswami RP, Pramanik N, Banerjee D, Raza MM, Guha SK, Maiti PK . Histoplasmosis in eastern India: the tip of the iceberg? Trans R Soc Trop Med Hyg 1999; 93: 540–542.
Sinha R, Raju S, Garg SP, Venkatesh P, Talwar D . Presumed ocular histoplasmosis syndrome in India. Immunol Inflamm 2007; 15: 315–317.
Hirano K, Tanikawa A, Miyake Y . Neovascular maculopathy associated with rubella retinopathy. Jpn J Ophthalmol 2000; 44: 697.
Veloso CE, Costa RA, Oréfice JL, Oréfice F . Spontaneous involution of choroidal neovascularization secondary to rubella retinopathy. Eye (Lond) 2007; 21: 1429–1430.
Viola F, Villani E, Mapelli C, Staurenghi G, Ratiglia R . Bilateral juvenile choroidal neovascularization associated with Best's vitelliform dystrophy: observation versus photodynamic therapy. J Pediatr Ophthalmol Strabismus 2010; 47: 121–122.
Leu J, Schrage NF, Degenring RF . Choroidal neovascularisation secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1723–1725.
Mandal S, Sinha S, Venkatesh P, Vashisht N . Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy. Indian J Ophthalmol 2011; 59: 262–263.
Rich R, Vanderveldt S, Berrocal AM, Mavrofrides EC, Murray TG, Gregori N . Treatment of choroidal neovascularization associated with Best's disease in children. J Pediatr Ophthalmol Strabismus 2009; 46: 306–311.
Jain K, Shafiq AE, Devenyi RG . Surgical outcome for removal of subfoveal choroidal neovascular membranes in children. Retina 2002; 22: 412–417.
Daniels AB, Jakobiec FA, Westerfeld CB, Hagiwara A, Michaud N, Mukai S . Idiopathic subfoveal choroidal neovascular membrane in a 21-month-old child: ultrastructural features and implication for membranogenesis. J AAPOS 2010; 14: 244–250.
Carneiro AM, Silva RM, Veludo MJ, Barbosa A, Ruiz-Moreno JM, Falcão MS et al. Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia. Ophthalmologica 2011; 225: 81–88.
Erkkilä H . Clinical appearance of optic disc drusen in childhood. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1975; 193: 1–18.
Gregory-Evans K, Rai P, Patterson J . Successful treatment of subretinal neovascularization with intravitreal ranibizumab in a child with optic nerve head drusen. J Pediatr Ophthalmol Strabismus 2009 e-pub 21 August 2009; doi:10.3928/01913913-20090818-03.
Sullu Y, Yildiz L, Erkan D . Submacular surgery for choroidal neovascularization secondary to optic nerve drusen. Am J Ophthalmol 2003; 136: 367–370.
Grossniklaus HE, Green WR . Pathologic findings in pathologic myopia. Retina 1992; 12: 127–133.
Ohno-Matsui K, Yoshida T, Futagami S, Yasuzumi K, Shimada N, Kojima A et al. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia. Br J Ophthalmol 2003; 87: 570–573.
Bottoni F, Tilanus M . The natural history of juxtafoveal and subfoveal choroidal neovascularization in high myopia. Int Ophthalmol 2001; 24: 249–255.
Potter MJ, Szabo SM, Ho T . Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl. Graefes Arch Clin Exp Ophthalmol 2006; 244: 639–641.
de Oliveira Dias JR, Rodrigues EB, Martinazzo M, Farah ME . Choroidal neovascularization in patient undergoing growth hormone treatment. Clin Ophthalmol 2009; 3: 89–90.
Rishi P, Rishi E, Venkatraman A . Intravitreal bevacizumab for treatment of choroidal neovascularization associated with osteogenesis imperfecta. Indian J Ophthalmol 2012; 60: 229–231.
Harissi-Dagher M, Sebag M, Gauthier D, Marcil G, Labelle P, Arbour JD . Photodynamic therapy in young patients with choroidal neovascularization following traumatic choroidal rupture. Am J Ophthalmol 2005; 139: 726–728.
Prasad A, Chirag CP, Puklin JE . Intravitreal bevacizumab in the treatment of choroidal neovascularization from a traumatic choroidal rupture in a 9-year-old child. Retinal Case Brief Rep 2009; 3: 125–127.
Piermarocchi S, Benetti E, Fracasso G . Intravitreal bevacizumab for posttraumatic choroidal neovascularization in a child. J AAPOS 2011; 15: 314–316.
Gross JG, King LP, de Juan E Jr, Powers T . Subfoveal neovascular membrane removal in patients with traumatic choroidal rupture. Ophthalmology 1996; 103: 579–585.
Abri A, Binder S, Pavelka M, Tittl M, Neumüller J . Choroidal neovascularization in a child with traumatic choroidal rupture: clinical and ultrastructural findings. Clin Experiment Ophthalmol 2006; 34: 460–463.
Klein R, Lewis RA, Meyers SM, Myers FL . Subretinal neovascularization associated with fundus flavimaculatus. Arch Ophthalmol 1978; 96: 2054–2057.
Endo K, Yuzawa M, Ohba N . Choroideremia associated with subretinal neovascular membrane. Acta Ophthalmol Scand 2000; 78: 483–486.
Rhee DY, Reichel E, Rogers A, Strominger M . Subfoveal choroidal neovascularization in a 3-year-old child with North Carolina macular dystrophy. J AAPOS 2007; 11: 614–615.
Mahajan VB, Russell SR, Stone EM . A new macular dystrophy with anomalous vascular development, pigment spots, cystic spaces, and neovascularization. Arch Ophthalmol 2009; 127: 1449–1457.
Lee EJ, Mavrikakis I, Fong K, Casswell AG . Primary peripapillary membrane in an 8-year-old boy. Eye (Lond) 2006; 20: 379–380.
Knape RM, Zavaleta EM, Clark CL 3rd, Khuddus N, Peden MC . Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen. J AAPOS 2011; 15: 87–90.
Mehta P, Puri P, Talbot JF . Disc drusen and peripapillary subretinal neovascular membrane in a child with the VACTERL association. Eye (Lond) 2006; 20: 847–848.
Mateo C, Moreno JG, Lechuga M, Adán A, Corcóstegui B . Surgical removal of peripapillary choroidal neovascularization associated with optic nerve drusen. Retina 2004; 24: 739–745.
Silva R, Torrent T, Loureiro R, Travassos A, de Abreu JR . Bilateral CNV associated with optic nerve drusen treated with photodynamic therapy with verteporfin. Eur J Ophthalmol 2004; 14: 434–437.
Nguyen C, Borruat FX . Bilateral peripapillary subretinal neovessel membrane associated with chronic papilledema: report of two cases. Klin Monatsbl Augenheilkd 2005; 222: 275–278.
Anderson CJ, Zavel DW, Schlagel TF Jr, Meyer SM . Bilateral juxtapapillary subretinal neovascularization and pseudopapilledema in a three year old child. J Pediatr Ophthalmol Strabismus 1978; 15: 296–299.
Kaeser PF, Borruat FX . Peripapillary neovascular membrane: a rare cause of acute vision loss in pediatric idiopathic intracranial hypertension. J AAPOS 2011; 15: 83–86.
Browning AC, Mengher LS, Gregson RM, Amoaku WM . Visual outcome of malignant hypertension in young people. Arch Dis Child 2001; 85: 401–403.
Kiss S, Rizzo JF III, Mukai S . Peripapillary choroidal neovascularization in children. Invest Ophthalmol Vis Sci 2005; 46, E-Abstract 4084.
Yıldırım C, Cetin EN, Yayla K, Avunduk AM, Yaylalı V . Photodynamic therapy for unilateral idiopathic peripapillary choroidal neovascularization in a child. Int Ophthalmol 2011; 31: 333–335.
Yedavally S, Frank RN . Peripapillary subretinal neovascularization associated with coloboma of the optic nerve. Arch Ophthalmol 1993; 111: 552–553.
Shaikh S, Trese M . Infantile choroidal neovascularization associated with choroidal coloboma. Retina 2003; 23: 585–586.
Rishi P, Sharma T, Gopal L . Photodynamic therapy for childhood choroidal neovascular membrane associated with Best's vitelliform dystrophy. Retinal Cases Brief Rep 2009; 3: 288–292.
Mimouni KF, Bressler SB, Bressler NM . Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children. Am J Ophthalmol 2003; 135: 900–902.
Kohly RP, Muni RH, Kertes PJ, Lam WC . Management of pediatric choroidal neovascular membranes with intravitreal anti-VEGF agents: a retrospective consecutive case series. Can J Ophthalmol 2011; 46: 46–50.
Kramer M, Axer-Siegel R, Jaouni T, Reich E, Hemo I, Priel E et al. Bevacizumab for choroidal neovascularization related to inflammatory diseases. Retina 2010; 30: 938–944.
Vinekar A, Sund N, Quiram P, Capone A Jr. . Choroidal neovascular membrane in persistent fetal vasculature syndrome managed with intravitreal pegaptanib sodium in an infant. Retina 2010; 30 (4 Suppl): S41–S44.
Avery RL . Extrapolating anti-vascular endothelial growth factor therapy into pediatric ophthalmology: promise and concern. J AAPOS 2009; 13: 329–331.
Coscas F, Querques G, Forte R, Terrada C, Coscas G, Souied EH . Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections. Retina 2012; 32: 1069–1076.
Sulzbacher F, Kiss C, Munk M, Deak G, Sacu S, Schmidt-Erfurth U . Diagnostic evaluation of type 2 (classic) choroidal neovascularization: optical coherence tomography, indocyanine green angiography, and fluorescein angiography. Am J Ophthalmol 2011; 152: 799–806.e1.
Dees C, Arnold JJ, Forrester JV, Dick AD . Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis. Arch Ophthalmol 1998; 116: 1456–1461.
Almony A, Thomas MA, Atebara NH, Holekamp NM, Del Priore LV . Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed ocular histoplasmosis syndrome. Ophthalmology 2008; 115: 540–545.e5.
Frank KE, Purnell EW . Subretinal neovascularization following rubella retinopathy. Am J Ophthalmol 1978; 86: 462–466.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on Eye website
Supplementary information
Rights and permissions
About this article
Cite this article
Rishi, P., Gupta, A., Rishi, E. et al. Choroidal neovascularization in 36 eyes of children and adolescents. Eye 27, 1158–1168 (2013). https://doi.org/10.1038/eye.2013.155
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2013.155
Keywords
This article is cited by
-
Choroidal neovascularization in 111 eyes of children and adolescents
International Ophthalmology (2022)
-
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
BMC Ophthalmology (2019)
-
Intravitreal Ranibizumab for the Treatment of Visual Impairment Due to Choroidal Neovascularization Associated with Rare Diseases: Cost-Effectiveness in the UK
Advances in Therapy (2019)
-
Clinical Efficacy and Safety of Current Interventions for Choroidal Neovascularization Associated with Rare Diseases: A Systematic Literature Review
Advances in Therapy (2018)
-
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy
International Ophthalmology (2018)
